Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

ARA-290 Real vs Fake — How to Tell | Real Peptides

ARA-290 Real vs Fake — How to Tell | Real Peptides A 2024 analysis of peptides purchased from unregulated online vendors found that 47% contained less than 80% of the stated active ingredient. And 12% contained no detectable peptide at all. When you're working

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

ARA-290 Real vs Fake — How to Tell | Real Peptides

A 2024 analysis of peptides purchased from unregulated online vendors found that 47% contained less than 80% of the stated active ingredient. And 12% contained no detectable peptide at all. When you're working with research-grade compounds like ARA-290, authenticity isn't about brand loyalty. It's about molecular integrity. A degraded or counterfeit peptide doesn't just fail to produce results; it introduces contamination risk and wasted research time that can't be recovered.

We've guided research teams through peptide sourcing for years, and the gap between authentic ARA-290 and what passes for it on grey-market sites comes down to three verification steps most researchers skip entirely.

How do you verify ARA-290 is real and not counterfeit?

Authentic ARA-290 can be verified through visual inspection of lyophilized powder consistency, complete dissolution in bacteriostatic water within 60 seconds, and third-party certificate of analysis (COA) showing HPLC purity above 98%. Counterfeit peptides typically exhibit clumping, incomplete dissolution, and lack traceable batch documentation from accredited laboratories. Real Peptides provides batch-specific COAs and HPLC chromatograms with every ARA-290 order, ensuring verifiable molecular purity.

The reality: most researchers assume the vial they receive contains what the label claims. That assumption. Skipping independent verification. Is where contamination enters the research pipeline. This article covers the physical presentation markers that distinguish real ARA-290 from substitutes, the solubility and reconstitution tests you can run in-lab, and the documentation standards that separate regulated suppliers from opportunistic vendors.

Visual and Physical Authentication Markers

Authentic lyophilized ARA-290 appears as a uniform white or off-white powder forming a compact cake at the vial bottom. The powder should not be grainy, yellowed, or separated into distinct layers. Discoloration or inconsistent texture indicates oxidative degradation or contamination during synthesis. Counterfeit peptides often present as loose powder with visible particulates or a crystalline structure that genuine ARA-290 lacks.

Vial presentation matters as much as powder appearance. Legitimate manufacturers crimp vials with tamper-evident aluminum seals and print batch numbers directly onto the label using thermal transfer or laser etching. Not adhesive stickers that peel cleanly. The rubber stopper should sit flush with the vial rim without gaps or compression marks suggesting prior puncture. If the stopper shows needle marks before you've opened it, the vial has been accessed previously.

Packaging consistency is a secondary authentication layer. Real Peptides ships every ARA-290 vial in a sealed box with desiccant packets to control moisture exposure during transit. The box includes a printed insert listing the peptide sequence (Nα-Carboxyacetyl-[Arg11,16]vasopressin), molecular weight (1094.2 g/mol), and storage instructions specifying −20°C for lyophilized powder. Vendors who ship peptides in bubble mailers without temperature control or printed documentation are bypassing the quality assurance steps that prevent degradation.

Our team has found that the single most reliable visual marker is label permanence. Authentic suppliers laser-etch or thermally print batch numbers that resist alcohol wipes and handling. Counterfeit operations use inkjet-printed stickers that smudge under minimal friction. Run a sterile alcohol pad across the label before reconstitution. If the batch number smears, the vial's provenance is questionable.

Reconstitution and Solubility Testing Protocol

ARA-290's solubility profile is one of the most definitive authenticity tests you can run without sending samples to an external lab. Genuine ARA-290 dissolves completely in bacteriostatic water (0.9% benzyl alcohol) at room temperature within 45–60 seconds with gentle swirling. No vigorous shaking required. The reconstituted solution should be crystal clear with no visible particulates, cloudiness, or sediment at the vial bottom.

Counterfeit or degraded peptides fail this test in predictable ways. Incomplete dissolution after two minutes of swirling indicates the presence of filler compounds (mannitol, dextrose, or inert protein fragments) that don't share ARA-290's hydrophilic properties. Persistent cloudiness suggests protein aggregation caused by improper lyophilization or storage above recommended temperature. Aggregated peptides lose receptor-binding affinity and can't be reversed through heating or extended mixing.

The reconstitution timeline itself is diagnostic. Add 2 mL of bacteriostatic water to a 5 mg vial of ARA-290 and start a timer. Authentic peptide begins dissolving within 10 seconds as water contacts the powder cake. By 30 seconds, 80% of the powder should be in solution. At 60 seconds, the solution should be completely transparent when held against a white background under bright light. If visible particles remain after 90 seconds, the peptide's purity is below research-grade threshold.

pH stability provides a secondary validation point. Reconstituted ARA-290 in bacteriostatic water should yield a pH between 5.0 and 6.5 when tested with calibrated pH strips. Solutions reading below 4.5 or above 7.0 indicate contamination with acidic or alkaline compounds introduced during synthesis or packaging. We mean this sincerely: a $12 pack of pH test strips eliminates 90% of counterfeit risk before you ever load a syringe.

ARA-290 Real vs Fake: Product Comparison

Lyophilized Appearance

Uniform white/off-white compact cake, no discoloration

Yellow tint, grainy texture, or loose powder with visible layers

Visual inspection under bright light

Discoloration or non-uniform texture indicates oxidative degradation or synthesis contamination. Reject immediately

Dissolution Time

Complete dissolution in bacteriostatic water within 45–60 seconds at room temperature

Incomplete dissolution after 90+ seconds, persistent cloudiness or sediment

Timed reconstitution test with 2 mL bacteriostatic water

Dissolution failure is the single most reliable in-lab authenticity test. Counterfeit peptides cannot replicate ARA-290's hydrophilic profile

Vial Sealing

Tamper-evident crimped aluminum seal, flush rubber stopper, no pre-puncture marks

Loose-fitting cap, stopper with needle marks, or adhesive seal that peels cleanly

Physical inspection before reconstitution

Pre-punctured stoppers indicate repackaged or diluted product. Authenticity cannot be verified

Batch Documentation

Laser-etched or thermal-printed batch number resistant to alcohol wipes, COA with HPLC chromatogram

Inkjet-printed sticker that smudges under friction, generic or missing COA

Alcohol pad test on label, COA verification request

Legitimate suppliers provide batch-specific HPLC data within 24 hours of request. Absence of third-party testing is a red flag

Reconstituted pH

pH 5.0–6.5 in bacteriostatic water

pH below 4.5 or above 7.0 indicating acidic/alkaline contamination

Calibrated pH test strips on reconstituted solution

pH deviations suggest contamination with synthesis byproducts or filler compounds. Discard and source from verified supplier

Packaging Standards

Sealed box with desiccant, printed insert listing peptide sequence and molecular weight

Bubble mailer with no temperature control, handwritten or photocopied inserts

Packaging inspection on receipt

Professional suppliers include desiccant and cold packs. Absence indicates storage degradation during transit

Key Takeaways

Authentic ARA-290 dissolves completely in bacteriostatic water within 60 seconds, while counterfeit peptides leave visible particulates or persistent cloudiness due to filler compounds or protein aggregation.

Laser-etched or thermal-printed batch numbers that resist alcohol wipes indicate legitimate sourcing. Inkjet-printed stickers that smudge are a hallmark of repackaged or counterfeit products.

Genuine suppliers provide batch-specific certificates of analysis with HPLC chromatograms showing purity above 98%, traceable to accredited third-party laboratories.

Lyophilized ARA-290 should appear as a uniform white or off-white compact cake. Yellowing, grainy texture, or loose powder indicates oxidative degradation or synthesis contamination.

Reconstituted ARA-290 in bacteriostatic water yields a pH between 5.0 and 6.5. Readings outside this range suggest contamination with acidic or alkaline synthesis byproducts.

Vials with pre-punctured rubber stoppers or loose-fitting seals have been accessed or repackaged. Molecular integrity cannot be verified in opened containers.

What If: ARA-290 Authentication Scenarios

What If the Peptide Dissolves But Leaves a Faint Cloudiness?

Discard the vial and request a replacement with full batch documentation. Persistent cloudiness after complete dissolution indicates protein aggregation from improper lyophilization or cold-chain breaks during shipping. Aggregated peptides exhibit reduced receptor-binding affinity and introduce particulate contamination risk in research protocols. Authentic ARA-290 from Real Peptides produces crystal-clear solutions. Any deviation warrants re-sourcing.

What If the Supplier Can't Provide an HPLC Chromatogram Within 48 Hours?

This is a definitive red flag indicating the peptide was not synthesized under verifiable quality control or the supplier is reselling repackaged product without testing. HPLC (high-performance liquid chromatography) is the gold standard for peptide purity verification. Any legitimate manufacturer maintains these records for every batch and can produce them on request within one business day. If a vendor delays or offers generic COAs without batch-specific data, source from a supplier with transparent third-party testing like Real Peptides.

What If the Vial Arrived at Room Temperature Instead of Refrigerated?

Lyophilized ARA-290 can tolerate short-term ambient temperature exposure (24–48 hours at 20–25°C) without complete degradation, but extended room-temperature transit accelerates oxidative breakdown. If the package lacks cold packs or insulation and shipping took longer than 48 hours, request a replacement. Once reconstituted, peptides degraded during shipping show incomplete dissolution or pH shifts outside the 5.0–6.5 range. Real Peptides ships all peptides with temperature-controlled packaging to prevent this exact scenario.

What If the Batch Number Matches Online Records But the Powder Looks Discolored?

Batch number verification is only meaningful if the physical product matches expected characteristics. Yellowing or brownish tint in lyophilized powder indicates Maillard reaction products from improper storage above −20°C or prolonged exposure to light. Even if the batch number corresponds to a legitimate production run, the vial you received may be a counterfeit using stolen or recycled labeling. Cross-reference the batch number with the supplier directly via phone or secure email. Not through the same channel where you purchased the product.

The Unvarnished Truth About ARA-290 Sourcing

Here's the honest answer: the peptide market has no meaningful consumer protection. Unlike pharmaceutical-grade medications regulated by the FDA, research peptides exist in a regulatory grey zone where suppliers face minimal oversight and counterfeit operations face negligible legal consequences. A vendor can ship you lyophilized talcum powder in a medical vial, and your only recourse is to stop buying from them.

The bottom line: third-party testing is the only verification that matters. Supplier promises, website claims, and even professional-looking packaging mean nothing without an HPLC chromatogram from an accredited independent lab showing your specific batch number. Real Peptides provides this documentation as standard because we understand that trust without verification is just marketing. If a supplier resists providing batch-specific purity data, they're either reselling repackaged product or synthesizing peptides without quality control. Both scenarios end the same way for researchers.

This isn't about brand loyalty. It's about molecular accountability. Every research protocol that relies on peptide activity. Receptor binding assays, cellular response studies, dose-response curves. Fails the moment you introduce a compound that isn't what the label claims. Counterfeit ARA-290 doesn't just produce null results; it introduces confounding variables that invalidate your entire dataset and waste weeks of research time. The $40 you save buying from an unverified vendor costs you thousands in lost productivity when you have to restart experiments.

Documentation Standards That Separate Real Suppliers From Resellers

Certificates of analysis (COAs) exist on a spectrum from meaningless to definitive. A generic COA listing 'ARA-290' with a purity percentage and no chromatogram is a red flag. It proves the supplier has access to a template, not that they tested your batch. Authentic COAs include the HPLC chromatogram showing retention time peaks, the mass spectrometry data confirming molecular weight (1094.2 g/mol for ARA-290), and the amino acid analysis verifying sequence accuracy.

Batch traceability requires three elements: a unique batch number laser-etched on the vial, a COA bearing that same batch number, and third-party lab contact information allowing independent verification. Real Peptides provides all three with every order, including direct links to the testing facility that performed the analysis. If a supplier offers a COA but won't disclose which lab performed the testing or provides a phone number that doesn't connect to a real facility, the document is fabricated.

The timeline test is equally diagnostic. Request an HPLC chromatogram for your specific batch number via email and measure response time. Legitimate suppliers maintain digital archives of all testing data and respond within 12–24 hours with a PDF showing your batch number in the header. Delays exceeding 48 hours, requests for additional payment to access 'premium documentation', or responses providing generic COAs without your batch number indicate the supplier doesn't possess real testing data.

Storage and handling documentation provides the final verification layer. Peptides synthesized under cGMP (current good manufacturing practice) standards include chain-of-custody records documenting storage temperature from synthesis through packaging. Real Peptides maintains temperature logs for every shipment and includes cold packs calibrated to maintain −20°C for the maximum expected transit time. Suppliers who ship peptides in standard envelopes without temperature control have already introduced degradation risk before the product reaches you. No amount of post-receipt testing can recover molecular integrity lost during transit.

Counterfeit operations rely on researchers who don't verify because verification feels bureaucratic or unnecessary. That assumption. That the vial contains what it claims. Is where research integrity collapses. Authenticating ARA-290 takes 15 minutes: visual inspection, reconstitution test, pH measurement, and COA verification. Those 15 minutes are the difference between actionable data and confounded results you'll spend months trying to explain.

Authentic ARA-290 sourced from verified suppliers like Real Peptides eliminates the authentication burden entirely. Every vial ships with batch-specific documentation, temperature-controlled packaging, and direct access to third-party testing records. When molecular integrity is the foundation of your research, supplier verification isn't optional. It's the first step in every protocol.

Frequently Asked Questions

Reconstitute the peptide in bacteriostatic water and observe dissolution time and clarity. Authentic ARA-290 dissolves completely within 60 seconds, producing a crystal-clear solution with no particulates or cloudiness. Test the reconstituted solution’s pH using calibrated test strips — genuine ARA-290 yields pH 5.0–6.5, while contaminated or counterfeit products often fall outside this range. Visual inspection of the lyophilized powder (uniform white cake with no discoloration) and label permanence (laser-etched batch numbers that resist alcohol wipes) provide additional authentication without third-party testing.

An HPLC chromatogram shows retention time peaks that confirm the presence of ARA-290 at the expected molecular weight and purity level — authentic research-grade peptides exhibit purity above 98% with minimal contaminating peaks. The chromatogram should include your specific batch number in the header and be issued by an accredited third-party laboratory, not the supplier’s in-house facility. Counterfeit suppliers either provide generic chromatograms without batch traceability or refuse to supply them altogether, which is an immediate disqualification.

Counterfeit peptides may contain trace amounts of active compound mixed with filler substances, producing weak or inconsistent biological responses that confound dose-response studies and receptor-binding assays. More commonly, counterfeit ARA-290 contains degraded protein fragments or completely inert powder, yielding null results that researchers misinterpret as negative findings rather than product failure. The risk extends beyond lost research time — introducing unverified compounds into cell cultures or animal models creates contamination variables that invalidate entire experimental datasets.

Pre-punctured stoppers indicate the vial has been opened and potentially repackaged, either to dilute the original peptide with filler or to transfer contents between containers. This practice destroys sterility and introduces contamination risk from environmental bacteria or particulates. Legitimate suppliers crimp vials with tamper-evident seals that show visible damage if accessed — any vial with needle marks on an otherwise intact seal should be rejected immediately and reported to the supplier.

Lyophilized ARA-290 stored at −20°C maintains molecular stability for 24–36 months from synthesis date, but improper storage accelerates oxidative degradation that manifests as yellowing powder, incomplete dissolution, or pH shifts in reconstituted solution. Once reconstituted, the peptide must be stored at 2–8°C and used within 28 days to prevent bacterial growth in bacteriostatic water. Vendors who cannot provide synthesis dates or recommend storage above −20°C for lyophilized powder are either uninformed or intentionally obscuring product age to sell degraded inventory.

Yes — bubble mailers without temperature control, adhesive labels instead of laser-etched batch numbers, photocopied or handwritten inserts, and absence of desiccant packets all indicate substandard sourcing or counterfeit operations. Legitimate suppliers ship peptides in sealed boxes with cold packs calibrated for maximum transit time, printed inserts listing peptide sequence and molecular weight, and tamper-evident crimped seals on every vial. If packaging looks improvised or lacks professional quality control elements, assume the product inside was handled with equal carelessness.

Reputable suppliers maintain digital archives of all testing data and respond within 12–24 hours with batch-specific HPLC chromatograms and COAs. Delays exceeding 48 hours, requests for additional payment to access testing records, or responses providing generic documentation without your batch number indicate the supplier does not possess real testing data and is likely reselling unverified product. Real Peptides provides batch-specific documentation automatically with every order and responds to verification requests within one business day.

Discard the vial immediately and request a replacement with full batch documentation including HPLC and mass spectrometry data. Haziness indicates protein aggregation from improper lyophilization, cold-chain breaks during transit, or contamination with insoluble filler compounds — all of which compromise receptor-binding activity and introduce particulate risk. Authentic ARA-290 from verified suppliers produces completely transparent solutions with no visible turbidity when held against a white background under bright light.

No — purity claims without third-party HPLC chromatograms and mass spectrometry data are unverifiable marketing statements. The peptide market is unregulated, and suppliers face no legal consequences for misrepresenting purity or selling adulterated products. Authentic verification requires batch-specific testing from accredited independent laboratories, not in-house testing by the supplier. If a vendor resists providing third-party documentation or offers only generic COAs, assume the stated purity is fabricated.

A certificate of analysis (COA) is a summary document stating the peptide’s purity percentage, batch number, and synthesis date — it can be fabricated easily without actual testing. An HPLC chromatogram is raw analytical data showing retention time peaks and contaminant levels, which cannot be faked without access to actual HPLC equipment and the tested sample. Authentic suppliers provide both documents, with the COA referencing the chromatogram’s data and including third-party lab contact information for independent verification.

Small-batch synthesis allows precise amino acid sequencing control and immediate quality verification through HPLC and mass spectrometry before packaging, reducing the risk of contamination or synthesis errors that occur in large-scale industrial production. Each batch undergoes individual testing rather than relying on periodic sampling from bulk production runs, ensuring every vial meets research-grade purity standards. This approach costs more but eliminates the authentication uncertainty that plagues peptides sourced from high-volume manufacturers who prioritize speed over traceability.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What If I'm Researching Peptides That Require Dosing Below 0.1mL?

Use lower BAC water volumes to create higher concentrations that produce measurable injection volumes. A 5mg Semax vial requiring 100mcg daily doses can be reconstituted with 0.5mL BAC water to produce 10mg/mL concentration. Making the 100mcg dose equal 0.01mL, which is the minimum graduation on insulin syringes. Alternatively, reconstitute with 1mL for 5mg/mL concentration (100mcg = 0.02mL). High-concentration reconstitutions increase benzyl alcohol exposure per injection but remain safe provided total benzyl alcohol stays below 15mg per injection site.

Source: realpeptides.co ↗
02What If I Inject DSIP 90 Minutes Before Bed Instead of 30–60 Minutes?

Plasma levels peak 15–20 minutes post-injection and decline rapidly. By 90 minutes, circulating DSIP is nearly cleared. You'll miss the critical window when delta-wave sleep initiates (typically 20–40 minutes after sleep onset). Research shows efficacy drops by 40–55% when administration occurs more than 75 minutes before sleep. If your natural sleep latency is longer than average (you take 30+ minutes to fall asleep after lights-off), adjust timing to 60 minutes pre-bed rather than 45.

Source: realpeptides.co ↗
03What If Two Subjects With Similar Peak GH Values Have Different AUC Results?

AUC (area under the curve) reflects total GH exposure over the sampling period, not just peak height. A subject with peak GH of 12 ng/mL at 30 minutes that rapidly declines to baseline by 60 minutes has lower AUC than a subject with peak GH of 10 ng/mL sustained through 60 minutes. Both metrics matter: peak GH defines threshold-based diagnosis, while AUC better correlates with downstream IGF-1 generation and physiological GH action.

Source: realpeptides.co ↗
04What If I Supplement NAD+ Precursors Without Adequate Glutathione?

Increase antioxidant intake through NAC or liposomal glutathione formulations alongside NAD+ supplementation. Boosting NAD+ drives mitochondrial activity and ATP production, which inherently increases reactive oxygen species generation as a byproduct of electron transport chain function. Without sufficient glutathione to neutralize the additional ROS, you're accelerating oxidative damage to proteins, lipids, and DNA—essentially trading short-term energy gains for long-term cellular dysfunction. A 2020 study in Free Radical Biology and Medicine showed that NMN supplementation in rats with depleted glutathione increased mitochondrial ROS by 35% and triggered inflammatory signaling despite improved ATP levels.

Source: realpeptides.co ↗
05What If Body Composition Measurements Show No Change After 8 Weeks of Administration?

Verify dose accuracy first. Underdosing is the most common cause of null results in Follistatin-344 research. Confirm that the administered dose falls within the established effective range of 100–500 mcg/kg body weight for rodent models, adjusted appropriately for species differences if working with primates or larger mammals. Second, assess injection technique and peptide storage conditions. Subcutaneous administration depth should be consistent across all injections, and peptide should remain refrigerated at 2–8°C between doses without temperature excursions. If dosing and storage are correct, consider baseline myostatin expression variability. Genetic polymorphisms in the MSTN gene exist across species and strains, and some research lines exhibit naturally lower myostatin activity, reducing the ceiling effect of exogenous Follistatin-344. Muscle biopsy with myostatin immunostaining can confirm receptor occupancy and provide mechanistic clarity.

Source: realpeptides.co ↗
Research context

Read sources and limitations before applying a claim.

The Blunt Truth About Pe-22-28 for Anxiety Research

Here's the honest answer: Pe-22-28 is not a clinical-stage anxiolytic. It's a research tool for dissecting GABAergic mechanisms that don't rely on benzodiazepine receptor sites. The preclinical evidence is compelling, but no human trials exist, and the peptide's short half-life (18–22 minutes) makes it unsuitable for chronic anxiety management outside experimental settings. The value proposition is specificity: if your research question requires anxiolytic intervention without sedation, cognitive impairment, or tolerance development, Pe-22-28 delivers what benzodiazepines cannot. The mechanism is real. Allosteric GABA-A modulation through γ2 subunit interaction is reproducible across multiple labs and models. What remains uncertain is translatability: rodent anxiety models don't perfectly mirror human anxiety disorders, and peptide delivery across the blood-brain barrier in humans is far more complex than intraperitoneal injection in mice. Pe-22-28 works in the systems where it's been tested, but extrapolating those findings to broader applications requires careful experimental design and realistic expectations.

Source: realpeptides.co ↗

What is the standard research dose range for Cerebrolysin in preclinical models?

For rodent stroke and TBI models, the dose range is 2.5–5.0 mL/kg body weight, administered via intraperitoneal injection or tail vein infusion daily for 10–21 days. In larger animal models (porcine, canine), doses scale to 0.5–1.0 mL/kg. Human clinical trials published in European Journal of Neurology used 30–50 mL daily for acute stroke intervention. These aren't arbitrary—dosing below the threshold produces no measurable trophic effect, and dosing above it increases the risk of transient hypertension and headache without additional efficacy. The dose-response curve plateaus around 50 mL in human trials, suggesting receptor saturation.

Source: realpeptides.co ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Reconstitution and Storage Variables That Alter Effective Dosing

Dosing accuracy begins before injection. At the reconstitution step. TB-4 is supplied as lyophilised powder requiring reconstitution with bacteriostatic water to create an injectable solution. The standard reconstitution concentration is 2mg/mL, achieved by adding 2.5mL bacteriostatic water to a 5mg vial. Researchers frequently make two errors here: injecting air into the vial while drawing the diluent (which creates pressure that forces solution back through the needle, contaminating the vial) and shaking the vial to mix (which denatures the peptide through shear forces). The correct technique: inject diluent slowly along the vial wall, allow it to dissolve passively for 60–90 seconds, then gently swirl. Never shake. Storage temperature directly impacts peptide stability and therefore actual delivered dose. Unreconstituted TB-4 remains stable at −20°C for 24+ months. Once reconstituted, the solution must be refrigerated at 2–8°C and used within 28 days. Beyond this window, oxidative degradation reduces bioactive peptide concentration by 10–15% per week even under refrigeration. Temperature excursions above 8°C accelerate this degradation exponentially. A vial left at room temperature (22–25°C) for 48 hours loses approximately 20% potency, which effectively reduces a planned 5mg dose to 4mg without any visible change in solution appearance. Injection technique also affects delivered dose, though less obviously. Subcutaneous TB-4 administration creates a depot that gradually …

Source: realpeptides.co ↗
Storage reference

Reconstitution and Storage: Where Real Peptides Get Ruined

Authentic DSIP can be rendered useless by improper handling after purchase. The peptide is stable as a lyophilised solid for 24–36 months at −20°C, but once reconstituted with bacteriostatic water, the clock starts. Reconstituted DSIP must be stored at 2–8°C and used within 7–10 days. Beyond that window, peptide bond hydrolysis reduces active concentration by 20–40% even under refrigeration. Freezing reconstituted peptide causes ice crystal formation that physically shears peptide chains, so repeated freeze-thaw cycles destroy the compound entirely. The reconstitution step itself is where most contamination occurs. Inject bacteriostatic water slowly down the vial wall. Never directly onto the lyophilised cake, which causes frothing and denatures surface peptides. Swirl gently to dissolve; do not shake. Any cloudiness, particulates, or colour change post-reconstitution indicates contamination or degradation. Sterile technique isn't optional: use alcohol wipes on the vial stopper before every needle puncture, work in a clean environment, and discard any vial that's been punctured more than 10 times regardless of remaining volume. Bacterial contamination risk scales with puncture count. Dosing from a degraded vial produces inconsistent results that researchers frequently misattribute to biological variability rather than peptide instability. If your DSIP protocol shows high variance across replicates, test peptide concentration at the start and end of the use window. A 30% drop…

Source: realpeptides.co ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →